Auddia Inc
AUUD4.700USD
+0.240+5.38%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
2.40MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Auddia Inc Unternehmen
Auddia Inc. is a technology company. The Company is focused on the development of a proprietary artificial intelligence (AI) platform for audio and technologies for podcasts. The Company is leveraging these technologies within its audio app, faidr. Its faidr enables the consumers to listen to any amplitude modulation (AM)/ frequency modulation (FM) radio station with commercial breaks replaced with personalized audio content, including popular and new music, news, and weather. The faidr includes podcasts and exclusive content, branded faidrRadio, which includes new artist discovery, curated music stations, and Music Casts. The Company has also developed a podcasting platform that provides a suite of tools that helps Podcasters create additional digital content for their podcast episodes as well as plan their episodes, build their brand, and monetize their content with new content distribution channels.
Unternehmensinformationen
BörsenkürzelAUUD
Name des UnternehmensAuddia Inc
IPO-datumFeb 17, 2021
CEODr. Jeffrey John Thramann, M.D.
Anzahl der mitarbeiter12
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 17
Addresse1680 38Th Street
StadtBOULDER
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl80301
Telefon13032199771
Websitehttps://auddia.com/
BörsenkürzelAUUD
IPO-datumFeb 17, 2021
CEODr. Jeffrey John Thramann, M.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jeffrey John Thramann, M.D.
Dr. Jeffrey John Thramann, M.D.
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
4.66K
+0.02%
Mr. Kirin M. Smith
Mr. Kirin M. Smith
President
President
--
--
Mr. John E. Mahoney
Mr. John E. Mahoney
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Shoebridge
Mr. Peter Shoebridge
Chief Technology Officer
Chief Technology Officer
--
-100.00%
Mr. Joshua Sroge
Mr. Joshua Sroge
Independent Director
Independent Director
--
--
Mr. Nick Balletta
Mr. Nick Balletta
Independent Director
Independent Director
--
--
Mr. Emmanuel De Boucaud
Mr. Emmanuel De Boucaud
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jeffrey John Thramann, M.D.
Dr. Jeffrey John Thramann, M.D.
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
4.66K
+0.02%
Mr. Kirin M. Smith
Mr. Kirin M. Smith
President
President
--
--
Mr. John E. Mahoney
Mr. John E. Mahoney
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Shoebridge
Mr. Peter Shoebridge
Chief Technology Officer
Chief Technology Officer
--
-100.00%
Mr. Joshua Sroge
Mr. Joshua Sroge
Independent Director
Independent Director
--
--
Mr. Nick Balletta
Mr. Nick Balletta
Independent Director
Independent Director
--
--
Umsatzaufteilung
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Wed, Jul 2
Aktualisiert: Wed, Jul 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Goldman Sachs & Company, Inc.
6.54%
White Lion Capital LLC
0.76%
Thramann (Jeffrey John)
0.75%
UBS Financial Services, Inc.
0.59%
The Vanguard Group, Inc.
0.06%
Other
91.30%
Aktionäre
Aktionäre
Anteil
Goldman Sachs & Company, Inc.
6.54%
White Lion Capital LLC
0.76%
Thramann (Jeffrey John)
0.75%
UBS Financial Services, Inc.
0.59%
The Vanguard Group, Inc.
0.06%
Other
91.30%
Aktionärstypen
Aktionäre
Anteil
Research Firm
6.54%
Individual Investor
0.84%
Venture Capital
0.76%
Investment Advisor
0.59%
Investment Advisor/Hedge Fund
0.06%
Hedge Fund
0.05%
Other
91.15%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
36
55.46K
8.94%
+37.01K
2025Q1
40
55.45K
9.13%
+36.45K
2024Q4
38
346.78K
6.11%
+134.22K
2024Q3
36
313.09K
9.98%
+61.17K
2024Q2
37
277.64K
9.87%
+19.60K
2024Q1
42
283.24K
10.40%
+52.58K
2023Q4
42
211.67K
25.49%
-39.82K
2023Q3
39
184.31K
22.07%
-27.22K
2023Q2
42
146.62K
26.09%
-101.61K
2023Q1
37
153.34K
29.83%
-44.06K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Goldman Sachs & Company, Inc.
40.60K
6.54%
+40.60K
--
Mar 31, 2025
White Lion Capital LLC
4.71K
0.76%
+4.71K
--
Mar 11, 2024
Thramann (Jeffrey John)
4.66K
0.75%
+1.00
+0.02%
Apr 04, 2025
UBS Financial Services, Inc.
3.63K
0.59%
+3.60K
+12424.14%
Mar 31, 2025
The Vanguard Group, Inc.
364.00
0.06%
--
--
May 31, 2025
Tower Research Capital LLC
301.00
0.05%
+3.00
+1.01%
Mar 31, 2025
Mahoney (John Edward)
162.00
0.03%
--
--
Apr 04, 2025
Deitsch (Stephen M)
152.00
0.02%
+1.00
+0.66%
Apr 04, 2025
Hanlon (Timothy J)
152.00
0.02%
+77.00
+102.67%
Apr 04, 2025
Birch (Thomas Carl)
76.00
0.01%
-75.00
-49.67%
Apr 04, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Mar 27, 2025
Merger
17<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Datum
Art
Verhältnis
Mar 27, 2025
Merger
17<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
